Literature DB >> 25955829

Function and mechanism of F-box proteins in gastric cancer (Review).

Jian Gong1, Juan Cao1, Guinan Liu1, Ji-Rong Huo1.   

Abstract

Gastric cancer (GC) is one of the commonest cancers with high mortality. Despite improvement in early detection and treatments, the outcome of advanced GC remains unsatisfactory due to the poor understanding of the intricate pathogenesis of GC. GC is a multifactorial and multistep disease which involves activation of oncogenes and inactivation of tumor suppressor genes. Ubiquitin proteasome system (UPS) catalyzing many critical protein substrates is involved in initiation and development of cancer. F-box proteins (FBPs) are the main functional components of UPS. Accumulated evidence strongly suggests that abnormal regulations of FBPs contribute to uncontrolled proliferation, genomic instability and cancer. In this review, we discuss how the dysregulated FBPs promote the occurrence and development of GC.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25955829     DOI: 10.3892/ijo.2015.2983

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  4 in total

Review 1.  F-box proteins involved in cancer-associated drug resistance.

Authors:  Jian Gong; Yuqian Zhou; Deliang Liu; Jirong Huo
Journal:  Oncol Lett       Date:  2018-04-16       Impact factor: 2.967

2.  Comprehensive Study of Human FBXW7 Deleterious nsSNP's Functional Inference and Susceptibility to Gynaecological Cancer.

Authors:  K Archana Vasuki; H Jemmy Christy
Journal:  Appl Biochem Biotechnol       Date:  2021-11-24       Impact factor: 2.926

3.  Fbxo45 promotes the malignant development of esophageal squamous cell carcinoma by targeting GGNBP2 for ubiquitination and degradation.

Authors:  Qi Wang; Linhui Wu; Ruoxue Cao; Jing Gao; Damin Chai; Yanzi Qin; Li Ma; Shiwu Wu; Yisheng Tao; Jia Ma; Zhi-Wei Wang
Journal:  Oncogene       Date:  2022-09-20       Impact factor: 8.756

4.  Xanthohumol, a prenylated flavonoid from Hops, exerts anticancer effects against gastric cancer in vitro.

Authors:  Shanshan Wei; Taoli Sun; Jie Du; Bikui Zhang; Daxiong Xiang; Wenqun Li
Journal:  Oncol Rep       Date:  2018-09-21       Impact factor: 3.906

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.